Appendix: A Starting Point for Parkinson’s? Many of the cancer what is programmed cell death called currently undergoing clinical trials target IAPs, since if the levels of IAPs are reduced, tumour cells will be destroyed by the body’s own self-protecting mechanism or by the chemotherapeutic drugs.
Did not find what they wanted? Try here
However, as a research group from the Goethe University in Frankfurt, working with scientists at the Universities of Würzburg and Philadelphia have recently discovered, IAPs also have another life: they control cell migration. Where IAP production is suppressed, there is a significant increase in C-RAF kinase, a crucial member of a signal cascade, which, among other functions, controls cell migration. This also means that when IAP levels are reduced, metastasis may be promoted unexpectedly in the absence of cell death. According to the researchers, drugs to target IAPs should therefore only be used with caution in future. Krishnaraj Rajalingam, leader of the Emmy-Noether Group at the Institute for Biochemistry at Frankfurt’s Goethe University, claims that these findings have been a great surprise. As he puts it: “Up until now, IAPs were well known for their role in apoptosis suppression, but we now realise that they can also influence other processes like cell migration”.